Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

Reynold Panettieri Jr,1 Njira Lugogo,2 Jonathan Corren,3 Christopher S Ambrose4 1Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, USA; 2Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USA; 3Departments of Medicine and Pediatric...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Dove Medical Press 2024-03-01
Цуврал:	Journal of Asthma and Allergy
Нөхцлүүд:	exacerbations eosinophilic allergic type 2 oral corticosteroid-dependent airway hyperresponsiveness
Онлайн хандалт:	https://www.dovepress.com/tezepelumab-for-severe-asthma-one-drug-targeting-multiple-disease-path-peer-reviewed-fulltext-article-JAA
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!